These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12667118)

  • 1. Docetaxel in non-small cell lung cancer: a review.
    Davies AM; Lara PN; Mack PC; Gandara DR
    Expert Opin Pharmacother; 2003 Apr; 4(4):553-65. PubMed ID: 12667118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy.
    Khuri FR
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):53-62. PubMed ID: 12108898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxanes for advanced non-small cell lung cancer.
    Ramalingam S; Belani CP
    Expert Opin Pharmacother; 2002 Dec; 3(12):1693-709. PubMed ID: 12472367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
    Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
    Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel (taxotere) in the treatment of non-small cell lung cancer.
    Georgoulias V
    Curr Med Chem; 2002 Apr; 9(8):869-77. PubMed ID: 11966449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxane-platinum combinations in advanced non-small cell lung cancer: a review.
    Rigas JR
    Oncologist; 2004; 9 Suppl 2():16-23. PubMed ID: 15161987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line chemotherapy for advanced-stage non-small-cell lung cancer: focus on docetaxel.
    Ramalingam S
    Clin Lung Cancer; 2005 Dec; 7 Suppl 3():S77-82. PubMed ID: 16384540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel: a review of its use in non-small cell lung cancer.
    Comer AM; Goa KL
    Drugs Aging; 2000 Jul; 17(1):53-80. PubMed ID: 10933515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel for previously treated non-small-cell lung cancer.
    Fossella FV
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):45-51. PubMed ID: 12108897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
    Belani CP
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer.
    Harper P
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-30-S14-32. PubMed ID: 9335522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Docetaxel (taxotere): current status of clinical development in non-small-cell bronchial carcinoma (NSCLC)].
    Manegold C
    Med Klin (Munich); 1998 Sep; 93 Suppl 3():16-21. PubMed ID: 9796220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer (NSCLC)--is there a role for a new chemotherapy programme?
    Armand JP
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():223-30. PubMed ID: 10895158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel and docetaxel combinations in non-small cell lung cancer.
    Belani CP
    Chest; 2000 Apr; 117(4 Suppl 1):144S-151S. PubMed ID: 10777470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel and radiation as combined-modality therapy.
    Kim ES; Khuri FR
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):97-105. PubMed ID: 12108904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer.
    Hainsworth JD; Vokes EE
    Semin Oncol; 2001 Feb; 28(1 Suppl 2):22-7. PubMed ID: 11284621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New options in the treatment of non-small cell lung cancer.
    Fossella F; Rigas JR; Belani CP
    Anticancer Drugs; 1999 Nov; 10 Suppl 1():S25-8. PubMed ID: 10630365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The taxoids. Comparative clinical pharmacology and therapeutic potential.
    Eisenhauer EA; Vermorken JB
    Drugs; 1998 Jan; 55(1):5-30. PubMed ID: 9463787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancer.
    Miller VA; Kris MG
    Semin Oncol; 2000 Apr; 27(2 Suppl 3):3-10. PubMed ID: 10810932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non--small cell lung cancer: focus on docetaxel.
    Gandara DR; Lara PN; Goldberg Z; Lau DH
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):26-32. PubMed ID: 11441412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.